Clinical Trials Logo
  1. Home
  2. Intra-Abdominal Infections
  3. NCT00827541

Post-Authorization Study Evaluating Safety Of Tigecycline — HORUS  

Intra-Abdominal Infections Clinical Trial

Official title:
A Phase IV Pharmacovigilance, Post-Authorization Clinical Trial To Evaluate And Assess The Safety Of Tigecycline In The Approved Indications In The Usual Health Care Setting

Clinical Trial Summary

This is a study to evaluate the safety of tigecycline in patients with complicated intra-abdominal infections (cIAI) and complicated skin and soft tissue infections (cSSTI) under real practice in the usual hospital setting and patients' conditions, in order to assess the "real incidence" of adverse events related with tigecycline in these patients.

Clinical Trial Description

Since around 50 patients were included in Spanish centers involved in the Phase III Tygacil clinical development program, and on the basis of the recruitment capacity of the centers within the predefined time window and the number of patients consenting to be enrolled in the study, the total number of patients estimated to be enrolled in the study is 500. With this sample size, it will be possible to obtain precise estimations of the incidence of particular types of adverse events. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00827541
Study type Observational
Source Pfizer
Contact
Status Completed
Phase N/A
Start date August 2008
Completion date December 2010
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT04240288 - Procalcitonin Guided Antibiotic Therapy N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT01473836 - A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection Phase 3
Terminated NCT03354754 - LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI) Phase 2
Completed NCT00965848 - A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections Phase 4
Completed NCT01506271 - Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004) Phase 2
Completed NCT05628493 - Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
Completed NCT02442596 - Abdominal SepsiS Study: Epidemiology of Etiology and Outcome N/A
Recruiting NCT04094818 - HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
Withdrawn NCT05639504 - Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)
Completed NCT01789905 - Tygacil Drug Use Investigation